Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Workplace Health & Safety
|
May 24, 2015
Metabolic Syndrome Prevalence and Correlates in a Worksite Wellness Program
Paige Johnson, Lori Turner, Melondie Carter, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
February 2, 2023
A Study of the Reliability, Validity, and Physiological Changes of Sit-to-Stand Tests in People With Heart Failure
Julie A Adsett, Rachel Bowe, Rebecca Kelly, et al.
American Journal of Health Promotion : AJHP
|
July 19, 2022
Health Benefits of a 16-Week Whole Food, High Fiber, Plant Predominant Diet among U.S. Employees
Rebecca Kelly, Amy Hanus, Pamela Payne-Foster, et al.
The New Zealand Medical Journal
|
August 23, 2014
The current state of ototoxicity monitoring in New Zealand
Lotte Steffens, Kinau Venter, Greg A O'Beirne, et al.
Cancer Biology & Therapy
|
June 7, 2012
The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models
Jennifer S Michaelson, Rebecca Kelly, Lu Yang, et al.
Respiratory Medicine
|
November 8, 2025
Student-delivered pulmonary and cardiac rehabilitation: Feasible, effective, and supports new care models
Kathleen Hall, Holly Pilgrim, Jacob Ehren, et al.
American Journal of Health Promotion : AJHP
|
November 30, 2019
The Art of Health Promotion: linking research to practice
Jessica Grossmeier, Sara S Johnson, Michael P O'Donnell, et al.
Mabs
|
June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 12, 2016
Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models
Antonio Boccia, Cyrus Virata, Daniel Lindner, et al.
Cancer Research
|
January 18, 2008
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism
Louise A Koopman Van Aarsen, Diane R Leone, Steffan Ho, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Workplace Health & Safety
|
May 24, 2015
Metabolic Syndrome Prevalence and Correlates in a Worksite Wellness Program
Paige Johnson, Lori Turner, Melondie Carter, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
February 2, 2023
A Study of the Reliability, Validity, and Physiological Changes of Sit-to-Stand Tests in People With Heart Failure
Julie A Adsett, Rachel Bowe, Rebecca Kelly, et al.
American Journal of Health Promotion : AJHP
|
July 19, 2022
Health Benefits of a 16-Week Whole Food, High Fiber, Plant Predominant Diet among U.S. Employees
Rebecca Kelly, Amy Hanus, Pamela Payne-Foster, et al.
The New Zealand Medical Journal
|
August 23, 2014
The current state of ototoxicity monitoring in New Zealand
Lotte Steffens, Kinau Venter, Greg A O'Beirne, et al.
Cancer Biology & Therapy
|
June 7, 2012
The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models
Jennifer S Michaelson, Rebecca Kelly, Lu Yang, et al.
Respiratory Medicine
|
November 8, 2025
Student-delivered pulmonary and cardiac rehabilitation: Feasible, effective, and supports new care models
Kathleen Hall, Holly Pilgrim, Jacob Ehren, et al.
American Journal of Health Promotion : AJHP
|
November 30, 2019
The Art of Health Promotion: linking research to practice
Jessica Grossmeier, Sara S Johnson, Michael P O'Donnell, et al.
Mabs
|
June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 12, 2016
Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models
Antonio Boccia, Cyrus Virata, Daniel Lindner, et al.
Cancer Research
|
January 18, 2008
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism
Louise A Koopman Van Aarsen, Diane R Leone, Steffan Ho, et al.
Page
of 3